Leaderboards/Diagnosis and treatment of tuberculosis

Diagnosis and treatment of tuberculosis

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Papers

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

Journal of Crohn s and Colitis|2024

315 cit.

Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas

International Journal of Radiation Oncology*Biology*Physics|2024

31 cit.

A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn’s disease

Journal of Crohn s and Colitis|2025

11 cit.

Microglia cannibalism and efferocytosis leads to shorter lifespans of developmental microglia

PLoS Biology|2024

8 cit.

Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993–2019

Open Forum Infectious Diseases|2024

7 cit.

The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management

Clinical Microbiology Reviews|2026

5 cit.

Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries

Vaccines|2024

3 cit.

Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence?

Journal of Respiration|2025

2 cit.

Exploring the learning preferences of farmworker‐serving community health workers

Health Information & Libraries Journal|2024

1 cit.

A Curious Case of Colitis

Gastroenterology|2024

1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Papers

Applying logistic LASSO regression for the diagnosis of atypical Crohn's disease

Scientific Reports|2022

239 cit.

Tuberculosis — United States, 2021

MMWR Morbidity and Mortality Weekly Report|2022

68 cit.

Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes Study

Vaccines|2022

67 cit.

Tuberculosis — United States, 2022

MMWR Morbidity and Mortality Weekly Report|2023

51 cit.

HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study

PLoS ONE|2022

45 cit.

Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020

Emerging infectious diseases|2022

23 cit.

Clinical outcomes after extended 12‐month antiretroviral therapy prescriptions in a community‐based differentiated HIV service delivery programme in South Africa: a retrospective cohort study

Journal of the International AIDS Society|2023

23 cit.

Development of Early-Life Gastrointestinal Microbiota in the Presence of Antibiotics Alters the Severity of Acute DSS-Induced Colitis in Mice

Microbiology Spectrum|2022

16 cit.

Epidemiology of Salmonellosis Among Infants in the United States: 1968–2015

PEDIATRICS|2023

16 cit.

Differentiating Crohn’s disease from intestinal tuberculosis using a fusion correlation neural network

Knowledge-Based Systems|2022

15 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Papers

Genes required for mycobacterial growth defined by high density mutagenesis

Molecular Microbiology|2003

2.6k cit.

Genetic requirements for mycobacterial survival during infection

Proceedings of the National Academy of Sciences|2003

1.4k cit.

Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis

Journal of Clinical Microbiology|2006

1.3k cit.

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

International Journal of Infectious Diseases|2021

1.1k cit.

Validation of housekeeping genes for normalizing RNA expression in real-time PCR

BioTechniques|2004

1k cit.

Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis

Journal of Clinical Microbiology|1991

1k cit.

Mandell, Douglas, and Bennett's principles and practice of infectious diseases

The Lancet Infectious Diseases|2010

990 cit.

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

Nature|2004

752 cit.

Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia

Journal of Clinical Microbiology|1995

712 cit.

Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages

Proceedings of the National Academy of Sciences|2005

684 cit.

Reagents for Diagnosis and treatment of tuberculosis

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 63

Phospho-GSK-3 alpha/beta (Ser21/9) (37F11) Rabbit Monoclonal Antibody

#9327$179,968

View Evidence →

Cell Signaling TechnologyEvidence 64

PathScan® Phospho-Tau (Ser214) Sandwich ELISA Kit

#44177$66,129,740

View Evidence →

Cell Signaling TechnologyEvidence 64

NAE1/APPBP1 (D9I4Z) Rabbit Monoclonal Antibody

#14321$161,351

View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

CD74 (F6K1S) Rabbit Monoclonal Antibody

Cited in 8 papers

#70167$161,376

View Evidence →

Cell Signaling TechnologyEvidence 64

LIMP-2/SCARB2 (E2Z5F) Rabbit Monoclonal Antibody (BSA and Azide Free)

#69463$865

View Evidence →

Cell Signaling TechnologyEvidence 65

Phospho-ATP-Citrate Lyase (Ser455) (F4T8R) Rabbit Monoclonal Antibody

#97366$200,479

View Evidence →

Diagnosis and treatment of tuberculosis

Rising Stars

Rising Stars Researchers

Rising Stars Papers

Emerging Leaders

Emerging Leaders Researchers

Emerging Leaders Papers

Current Senior Leaders

Current Senior Leaders Researchers

Current Senior Leaders Papers

Reagents for Diagnosis and treatment of tuberculosis

🔥 Trending

⭐ Top Rated

🌟 All-Time